FOLFOX-话题@MedSci

#FOLFOX#

43篇内容 | 2292人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1455459, encodeId=3f36145545956, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=DCR：化放疗后巩固mFOLFOX6化疗可改善晚期直肠癌患者的生存率, objectType=article, longId=150473, objectId=28f61504e3f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28f61504e3f0, replyNumber=0, likeNumber=81, createdTime=2018-10-08, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28f61504e3f0, moduleTitle=DCR：化放疗后巩固mFOLFOX6化疗可改善晚期直肠癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28f61504e3f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455458, encodeId=36f5145545841, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=J Clin Oncol：RAS野生型转移性结直肠癌：西妥昔单抗联合FOLFOX-4 vs FOLFOX-4, objectType=article, longId=149868, objectId=57f314986823, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57f314986823, replyNumber=0, likeNumber=73, createdTime=2018-09-30, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57f314986823, moduleTitle=J Clin Oncol：RAS野生型转移性结直肠癌：西妥昔单抗联合FOLFOX-4 vs FOLFOX-4, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57f314986823)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455457, encodeId=fce9145545ed4, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=JCO：Cetuximab联合FOLFOX-4治疗RAS野生型转移性结直肠癌, objectType=article, longId=148749, objectId=88ec148e49bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88ec148e49bc, replyNumber=0, likeNumber=58, createdTime=2018-09-14, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88ec148e49bc, moduleTitle=JCO：Cetuximab联合FOLFOX-4治疗RAS野生型转移性结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88ec148e49bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455456, encodeId=53071455456d0, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=CLIN CANCER RES：Andecaliximab单药或联合mFOLFOX6治疗晚期胃及胃食管交界处腺癌, objectType=article, longId=147490, objectId=2c3e14e490ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c3e14e490ab, replyNumber=0, likeNumber=104, createdTime=2018-08-28, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c3e14e490ab, moduleTitle=CLIN CANCER RES：Andecaliximab单药或联合mFOLFOX6治疗晚期胃及胃食管交界处腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c3e14e490ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455455, encodeId=af4114554551c, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=J Hepatol：FOLFOX肝动脉灌注可改善晚期肝细胞癌生存率？, objectType=article, longId=146110, objectId=147214611030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=147214611030, replyNumber=0, likeNumber=62, createdTime=2018-08-09, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=147214611030, moduleTitle=J Hepatol：FOLFOX肝动脉灌注可改善晚期肝细胞癌生存率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=147214611030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455454, encodeId=919014554544a, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=ANN ONCOL：转移性结直肠癌原发肿瘤部位与FOLFOXIRI联合贝伐单抗治疗获益的关系, objectType=article, longId=145446, objectId=b3c2145446b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3c2145446b6, replyNumber=0, likeNumber=70, createdTime=2018-07-31, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3c2145446b6, moduleTitle=ANN ONCOL：转移性结直肠癌原发肿瘤部位与FOLFOXIRI联合贝伐单抗治疗获益的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3c2145446b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455453, encodeId=207c1455453aa, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=JAMA ONCOL：西妥昔单抗+改良FOLFOXIR后持续西妥昔单抗或贝伐单抗治疗RAS和BRAF野生型转移性结直肠癌I, objectType=article, longId=136508, objectId=62cf1365087c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62cf1365087c, replyNumber=0, likeNumber=75, createdTime=2018-04-27, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62cf1365087c, moduleTitle=JAMA ONCOL：西妥昔单抗+改良FOLFOXIR后持续西妥昔单抗或贝伐单抗治疗RAS和BRAF野生型转移性结直肠癌I, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62cf1365087c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455452, encodeId=1844145545294, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=EUR J Cancer：FOLFOXIRI联合贝伐单抗治疗肝脏转移性结直肠癌的必要性, objectType=article, longId=125225, objectId=7dbb1252255e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7dbb1252255e, replyNumber=0, likeNumber=0, createdTime=2018-01-02, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7dbb1252255e, moduleTitle=EUR J Cancer：FOLFOXIRI联合贝伐单抗治疗肝脏转移性结直肠癌的必要性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7dbb1252255e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455451, encodeId=1937145545196, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=EUR J Cancer：FOLFOXIRI联合贝伐单抗治疗肝脏限制性转移性结直肠癌的疗效观察, objectType=article, longId=125223, objectId=376b12522337, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=376b12522337, replyNumber=0, likeNumber=0, createdTime=2018-01-02, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=376b12522337, moduleTitle=EUR J Cancer：FOLFOXIRI联合贝伐单抗治疗肝脏限制性转移性结直肠癌的疗效观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=376b12522337)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455450, encodeId=e0ac145545002, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=局部晚期直肠癌：改良 FOLFOX6 方案可供参考, objectType=article, longId=77194, objectId=1021e71948c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1021e71948c, replyNumber=0, likeNumber=86, createdTime=2016-09-12, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1021e71948c, moduleTitle=局部晚期直肠癌：改良 FOLFOX6 方案可供参考, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1021e71948c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455449, encodeId=230f1455449e5, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=mFOLFOX6联合同期新辅助放疗治疗局部进展期直肠癌（FOWARC研究）, objectType=article, longId=56656, objectId=92745665668, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92745665668, replyNumber=0, likeNumber=72, createdTime=2015-09-29, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92745665668, moduleTitle=mFOLFOX6联合同期新辅助放疗治疗局部进展期直肠癌（FOWARC研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92745665668)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455448, encodeId=6234145544846, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=Lancet Oncol:增加mFOLFOX6改善直肠癌患者预后, objectType=article, longId=53488, objectId=827353488e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=827353488e2, replyNumber=0, likeNumber=0, createdTime=2015-07-19, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=827353488e2, moduleTitle=Lancet Oncol:增加mFOLFOX6改善直肠癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=827353488e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455447, encodeId=54c2145544e91, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=ASCO 2015：中国直肠癌研究FOWARC发现围手术期应用mFOLFOX6化疗方案可能改善DFS, objectType=article, longId=51775, objectId=bc6051e753f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc6051e753f, replyNumber=0, likeNumber=52, createdTime=2015-06-09, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc6051e753f, moduleTitle=ASCO 2015：中国直肠癌研究FOWARC发现围手术期应用mFOLFOX6化疗方案可能改善DFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc6051e753f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455446, encodeId=bc0514554467c, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=CCC：Tivozanib联合mFOLFOX6方案治疗进展期胃肠道恶性肿瘤疗效满意, objectType=article, longId=44484, objectId=63814448489, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63814448489, replyNumber=0, likeNumber=85, createdTime=2014-12-24, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63814448489, moduleTitle=CCC：Tivozanib联合mFOLFOX6方案治疗进展期胃肠道恶性肿瘤疗效满意, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63814448489)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455445, encodeId=5e961455445a8, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=NEJM：FOLFOXIRI和贝伐单抗用于转移性结直肠癌的初始治疗, objectType=article, longId=41741, objectId=b70f41e41b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b70f41e41b1, replyNumber=0, likeNumber=72, createdTime=2014-10-26, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b70f41e41b1, moduleTitle=NEJM：FOLFOXIRI和贝伐单抗用于转移性结直肠癌的初始治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b70f41e41b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455444, encodeId=65bf145544405, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=S-1/奥沙利铂 (SOX)联合贝伐珠单抗与5-FU/l-LV/奥沙利铂(mFOLFOX6)联合贝伐珠单抗治疗转移性结直肠癌(mCRC)(SOFT研究), objectType=article, longId=37048, objectId=c4a63e048dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4a63e048dd, replyNumber=0, likeNumber=88, createdTime=2014-06-27, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4a63e048dd, moduleTitle=S-1/奥沙利铂 (SOX)联合贝伐珠单抗与5-FU/l-LV/奥沙利铂(mFOLFOX6)联合贝伐珠单抗治疗转移性结直肠癌(mCRC)(SOFT研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4a63e048dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455443, encodeId=4c6c145544391, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=ASCO 2014：Ramucirumab+FOLFOX作为晚期胃/食管癌一线治疗？, objectType=article, longId=35753, objectId=591235e53d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=591235e53d6, replyNumber=0, likeNumber=74, createdTime=2014-06-04, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=591235e53d6, moduleTitle=ASCO 2014：Ramucirumab+FOLFOX作为晚期胃/食管癌一线治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=591235e53d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455442, encodeId=bc1c1455442f9, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=Lancet Oncol：FOLFOX方案加西妥昔单抗用于结直肠癌维持治疗方案（COIN-B研究）, objectType=article, longId=33905, objectId=599233905c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=599233905c3, replyNumber=0, likeNumber=75, createdTime=2014-04-30, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=599233905c3, moduleTitle=Lancet Oncol：FOLFOX方案加西妥昔单抗用于结直肠癌维持治疗方案（COIN-B研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=599233905c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455441, encodeId=9a8e14554412c, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=Lancet Oncol：推荐局灶性食管癌应用FOLFOX联合同步放疗, objectType=article, longId=31490, objectId=16a331490a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16a331490a8, replyNumber=0, likeNumber=81, createdTime=2014-03-06, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16a331490a8, moduleTitle=Lancet Oncol：推荐局灶性食管癌应用FOLFOX联合同步放疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16a331490a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455440, encodeId=fb291455440aa, content=<a href='/topic/show?id=d0cee572e9' target=_blank style='color:#2F92EE;'>#FOLFOX#</a>, objectTitle=JCO：秦叔逵-FOLFOX4方案或让亚洲肝癌患者获益, objectType=article, longId=23586, objectId=a4d02358610, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4d02358610, replyNumber=0, likeNumber=72, createdTime=2013-09-04, rootId=0, userName=linlin2314, userId=12f25658567, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4d02358610, moduleTitle=JCO：秦叔逵-FOLFOX4方案或让亚洲肝癌患者获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4d02358610)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

FOLFOX

2020-05-29

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

DCR：化放疗后巩固mFOLFOX6化疗可改善晚期直肠癌患者的生存率

2018-10-08

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

J Clin Oncol：RAS野生型转移性结直肠癌：西妥昔单抗联合FOLFOX-4 vs FOLFOX-4

2018-09-30

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

JCO：Cetuximab联合FOLFOX-4治疗RAS野生型转移性结直肠癌

2018-09-14

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

CLIN CANCER RES：Andecaliximab单药或联合mFOLFOX6治疗晚期胃及胃食管交界处腺癌

2018-08-28

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

J Hepatol：FOLFOX肝动脉灌注可改善晚期肝细胞癌生存率？

2018-08-09

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

ANN ONCOL：转移性结直肠癌原发肿瘤部位与FOLFOXIRI联合贝伐单抗治疗获益的关系

2018-07-31

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

JAMA ONCOL：西妥昔单抗+改良FOLFOXIR后持续西妥昔单抗或贝伐单抗治疗RAS和BRAF野生型转移性结直肠癌I

2018-04-27

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

EUR J Cancer：FOLFOXIRI联合贝伐单抗治疗肝脏转移性结直肠癌的必要性

2018-01-02

医者仁心 (审核中...)

前往app查看评论内容

#FOLFOX#

EUR J Cancer：FOLFOXIRI联合贝伐单抗治疗肝脏限制性转移性结直肠癌的疗效观察

2018-01-02

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

局部晚期直肠癌：改良 FOLFOX6 方案可供参考

2016-09-12

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

mFOLFOX6联合同期新辅助放疗治疗局部进展期直肠癌（FOWARC研究）

2015-09-29

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

Lancet Oncol:增加mFOLFOX6改善直肠癌患者预后

2015-07-19

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

ASCO 2015：中国直肠癌研究FOWARC发现围手术期应用mFOLFOX6化疗方案可能改善DFS

2015-06-09

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

CCC：Tivozanib联合mFOLFOX6方案治疗进展期胃肠道恶性肿瘤疗效满意

2014-12-24

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

NEJM：FOLFOXIRI和贝伐单抗用于转移性结直肠癌的初始治疗

2014-10-26

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

S-1/奥沙利铂 (SOX)联合贝伐珠单抗与5-FU/l-LV/奥沙利铂(mFOLFOX6)联合贝伐珠单抗治疗转移性结直肠癌(mCRC)(SOFT研究)

2014-06-27

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

ASCO 2014：Ramucirumab+FOLFOX作为晚期胃/食管癌一线治疗？

2014-06-04

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

Lancet Oncol：FOLFOX方案加西妥昔单抗用于结直肠癌维持治疗方案（COIN-B研究）

2014-04-30

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

Lancet Oncol：推荐局灶性食管癌应用FOLFOX联合同步放疗

2014-03-06

linlin2314 (审核中...)

前往app查看评论内容

#FOLFOX#

JCO：秦叔逵-FOLFOX4方案或让亚洲肝癌患者获益

2013-09-04

科室
- - 订阅+
  - 更多科室
工具
服务